Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020

被引：2
|
作者：
Moneer, Osman [1 ,2 ]
Lee, ChangWon C. [1 ]
Avorn, Jerry [1 ]
Kesselheim, Aaron S. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon,Program Regu, Boston, MA 02115 USA
[2] Yale Univ, Yale Sch Med, New Haven, CT USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2021.8530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] An Analysis of Dosing-Related Postmarketing Requirements for Novel Oncology Drugs Approved by the US Food and Drug Administration, 2012-2022
    Collins, Grace
    McKelvey, Brittany
    Andrews, Hillary S.
    Allen, Jeff D.
    Stewart, Mark D.
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 937 - 941
  • [22] Association of expedited review programmes with postmarketing safety events of new drugs approved by the US food and drug administration between 2007 and 2017
    Zhu, Xingyue
    Liu, Bao
    BMJ OPEN, 2022, 12 (07):
  • [23] US Food and Drug Administration Revises Recommendations for Rotavirus Vaccines
    不详
    NEWBORN AND INFANT NURSING REVIEWS, 2010, 10 (04) : E13 - E13
  • [24] Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration
    Sullivan, Kathleen M.
    Dores, Graca M.
    Nayernama, Afrouz
    Prowell, Tatiana M.
    Pradhan, Shan M.
    Osgood, Christy
    Jones, S. Christopher
    JAMA ONCOLOGY, 2022, 8 (10) : 1503 - 1505
  • [25] Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled Trials
    Shepshelovich, Daniel
    Tibau, Ariadna
    Goldvaser, Hadar
    Ocana, Alberto
    Seruga, Bostjan
    Amir, Eitan
    MAYO CLINIC PROCEEDINGS, 2019, 94 (01) : 74 - 83
  • [26] Estratest is not approved by the Food and Drug Administration
    Suthers, Kristen
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (02) : 205 - 206
  • [27] Food and drug administration chief approved
    不详
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (02) : 57 - 58
  • [28] US FOOD AND DRUG ADMINISTRATION (FDA) POSTMARKETING REQUIREMENTS AND COMMITMENTS RELATED TO DRUG DISPOSITION IN LACTATION AND PREGNANCY
    Ridge, S.
    Ramamoorthy, A.
    Guinn, D.
    Zineh, I.
    Fletcher, E. Pfuma
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S77 - S77
  • [29] Real-world evidence for US Food and Drug Administration-approved oncology products, 2015 to 2020.
    Arondekar, Bhakti
    Duh, Mei Sheng
    Bhak, Rachel
    DerSarkissian, Maral
    Huynh, Lynn
    Wang, Kelsey
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [30] UPDATED 2018-2020 REVIEW OF PATIENT-REPORTED OUTCOMES IN ORPHAN DRUG LABELS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION
    Hajdukova, Brown E.
    Girardi, A.
    Rzepa, E.
    Scippa, K.
    Rudell, K.
    VALUE IN HEALTH, 2022, 25 (01) : S227 - S228
12345